This page provides news and updates for Applied Genetic Technologies Corporation (AGTC), a clinical-stage biotechnology company that developed AAV-based gene therapies for rare ophthalmic, otologic, and CNS diseases. The archive details the company's acquisition by a Syncona Limited portfolio company, which led to AGTC becoming a wholly-owned subsidiary and its delisting from Nasdaq in late 2022. It also tracks the subsequent continuation of AGTC's legacy XLRP asset under Beacon Therapeutics, including recent positive Phase 2 interim data.

Infosys, TCS, and Wipro have significantly expanded their Microsoft 365 Copilot deployments, collectively surpassing 300,000 licenses, representing a major acceleration in enterprise AI adoption within India's IT services sector. This expansion, more than doubling adoption in six months, underscores a global trend towards integrating AI into daily workflows for tasks ranging from content creation to workflow automation. The companies report high active usage rates and significant productivity gains, indicating a shift from limited pilots to widespread implementation of "agentic AI" in daily operations.

Bank of New York Mellon Corp increased its stake in Honeywell International Inc. by 2.3% in the fourth quarter, acquiring an additional 149,155 shares to bring its total holdings to 6.61 million shares valued at approximately $1.29 billion. Institutional investors own a significant 75.91% of Honeywell stock, with several other firms also boosting their positions. Analysts currently rate Honeywell as a "Moderate Buy" with an average target price of $247.29, despite recent mixed earnings results where EPS beat estimates but revenue slightly missed.

Morgan Stanley downgraded Shake Shack (NYSE:SHAK) to Equalweight from Overweight and lowered its price target to $76 from $115 following two consecutive guidance reductions. The stock is currently trading near its 52-week low and is down 55% over the past year. This decision comes after Shake Shack revised its financial guidance for Q2 and the full fiscal year 2026 due to macroeconomic uncertainty and a competitive market, despite the platform’s Fair Value analysis suggesting the stock may be undervalued.

Bank of New York Mellon Corp reduced its stake in Philip Morris International Inc. by 30.3% in the fourth quarter, selling over 4 million shares but still holding 9.37 million shares valued at about $1.5 billion. Despite this, analysts generally maintain a "Moderate Buy" rating for PM with an average price target of $192.56. Philip Morris recently exceeded quarterly earnings and revenue expectations ($1.96 EPS on $10.15 billion revenue) and declared a dividend of $1.47 per share, although the company has faced negative headlines including a profit forecast cut due to a Canadian writedown and cost pressures.

Bank of New York Mellon Corp increased its stake in Intuit Inc. by 20.3% in the fourth quarter, purchasing an additional 471,451 shares to bring its total holding to 2.79 million shares valued at approximately $1.85 billion. This increase comes despite recent pressures on Intuit's stock, including analyst downgrades and legal investigations, even as the company reported better-than-expected earnings and raised its guidance. Other hedge funds have also adjusted their positions in Intuit, with some increasing their holdings and others initiating new ones.

HCA Healthcare has returned $39 billion to shareholders over the past five years through dividends and buybacks, ranking it 45th historically among companies for capital returns. While high capital returns are attractive, the article also advises investors to assess if such returns come at the expense of growth and strong fundamentals, comparing HCA's performance and valuation with the S&P 500 median and its peers. The analysis also emphasizes the importance of staying invested through a diversified portfolio to navigate market volatility and benefit from long-term returns.

Bank of New York Mellon Corp increased its stake in Freeport-McMoRan Inc. by 4.7% in the fourth quarter, acquiring an additional 1,014,200 shares, bringing its total holding to 22.7 million shares valued at approximately $1.15 billion. Other institutional investors also adjusted their positions. Analyst sentiment remains largely positive with a "Moderate Buy" consensus and a price target of $66.04, following the company's strong quarterly earnings that surpassed estimates.

Bridges Investment Management Inc. reduced its stake in PepsiCo by 8.2% in the fourth quarter, selling 16,781 shares, but still holds 188,855 shares valued at $27.1 million. The reduction comes despite PepsiCo reporting better-than-expected earnings and revenue, while also increasing its quarterly dividend and continuing a $10 billion share buyback program. Analysts generally maintain a "Hold" rating on PepsiCo, with an average price target of $170.11.

GCQ FUNDS MANAGEMENT PTY Ltd has significantly increased its stake in Amazon.com, Inc. (AMZN) by 14.1% in the fourth quarter, making it their largest holding. This move underscores strong institutional support for Amazon, with 72.20% of the stock now held by institutional investors despite recent insider sales. Analysts maintain a "Moderate Buy" rating for Amazon, citing the success of Prime Day, new AI features, and growth in its cloud and AI businesses.